Candel Therapeutics, Inc. announced that Francesca Barone has been named as the company's Chief Scientific Officer. Dr. Barone brings more than 20 years of experience in immunology, experimental medicine, and innovative drug development to help bring important new therapeutics to the clinic. Dr. Barone was previously the company's Vice President, Head of Research having joined the company in November 2020.